High SET protein levels are also associated with poor prognosis of metastatic colon cancer, non-small-cell lung cancer, pancreatic cancer, gastric cancer, liver cancer, CML, AML, and lymphoma16–22. The gene discussed is SET; the disease is liver cancer.